Cardiac troponin I mutations in Australian families with hypertrophic cardiomyopathy: Clinical, genetic and functional consequences

Journal of Molecular and Cellular Cardiology

Volumn 38, Issue 2, 2005, Pages 387-393

  Doolan, Alessandra ^a   Tebo, Molly ^a   Ingles, Jodie ^a   Nguyen, Lan ^a   Tsoutsman, Tatiana ^a   Lam, Lien ^a   Chiu, Christine ^a   Chung, Jessica ^a   Weintraub, Robert G ^b   Semsarian, Christopher ^a,c  

^a CENTENARY INSTITUTE   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Cardiomyopathy; Hypertrophy; Interactions; Troponin complex; Troponin I

Indexed keywords

AMINO ACID; TROPONIN I;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL FEATURE; CODON; CORRELATION ANALYSIS; DISEASE SEVERITY; EXON; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC ANALYSIS; HEART ARREST; HEART DEATH; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROTEIN INTERACTION; TWO HYBRID SYSTEM;

MAMMALIA;

EID: 20844448376     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2004.12.006     Document Type: Article

References (24)

1. J. Chung, T. Tsoutsman, and C. Semsarian Hypertrophic cardiomyopathy: from gene defect to clinical disease Cell Res. 13 2003 9 20
2. B.J. Maron, J.M. Gardin, J.M. Flack, S.S. Gidding, and D. Bild Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA Study Circulation 92 1995 785 789
3. J.G. Seidman, and C.E. Seidman The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms Cell 104 2001 557 567
4. A. Doolan, L. Nguyen, and C. Semsarian Hypertrophic cardiomyopathy: from "heart tumour" to a complex molecular genetic disorder Heart Lung Circ. 13 2004 15 25
5. A. Kimura, H. Harada, J.E. Park, H. Nishi, M. Satoh, and M. Takahashi Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy Nat. Genet. 16 1997 379 382
6. J. Mogensen, T. Kubo, M. Duque, W. Uribe, A. Shaw, and R. Murphy Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations J. Clin. Invest. 111 2003 209 216
7. R.T. Murphy, J. Mogensen, A. Shaw, T. Kubo, S. Hughes, and W.J. McKenna Novel mutation in cardiac troponin I in recessive idiopathic dilated cardiomyopathy Lancet 363 2004 371 372
8. I. Jayatilleke, A. Doolan, J. Ingles, M. McGuire, V. Booth, and D.R. Richmond Long term follow-up of implantable cardioverter-defibrillator therapy for hypertrophic cardiomyopathy Am. J. Cardiol. 93 2004 1192 1194
9. P. Richard, P. Charron, L. Carrier, C. Ledeuil, T. Cheav, and C. Pichereau Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications on a molecular diagnosis strategy Circulation 107 2003 2227 2232
10. http://genetics.med.harvard.edu/∼seidman/cg3/muts/ TNNI3_mutations_TOC.html.
11. H. Kokado, M. Shimizu, H. Yoshio, H. Ino, K. Okeie, and Y. Emoto Clinical features of hypertrophic cardiomyopathy caused by a Lys183 deletion mutation in the cardiac troponin I gene Circulation 102 2000 663 669
12. S. Morner, P. Richard, E. Kazzam, B. Hainque, K. Schwartz, and A. Waldenstrom Deletion in the cardiac troponin I gene in a family from northern Sweden with hypertrophic cardiomyopathy J. Mol. Cell. Cardiol. 32 2000 521 525
13. H. Niimura, K. Patton, W. McKenna, J. Soults, B.J. Maron, and J.G. Seidman Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly Circulation 105 2002 446 451
14. P. Spirito, P. Bellone, K.M. Harris, P. Bernado, P. Bruzzi, and B.J. Maron Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy N. Engl. J. Med. 15 2000 1778 1785
15. P.M. Elliott, J.R. Gimeno Blanes, N.G. Mahon, J.D. Poloniecki, and W.J. McKenna Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy Lancet 357 2001 420 424
16. F. Takahashi-Yanaga, S. Morimoto, K. Harada, R. Minakami, F. Shiraishi, and M. Ohta Functional consequences of the mutations in human cardiac troponin I gene found in familial hypertrophic cardiomyopathy J. Mol. Cell. Cardiol. 33 2001 2095 2107
17. K. Elliott, H. Watkins, and C.S. Redwood Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy J. Biol. Chem. 275 2000 22069 22074
18. J. James, Y. Zhang, H. Osinska, A. Sanbe, R. Klevitsky, and T.E. Hewett Transgenic modeling of a cardiac troponin I mutation linked to familial hypertrophic cardiomyopathy Circ. Res. 87 2000 805 811
19. R. Lang, A.V. Gomes, J. Zhao, P.R. Housmans, T. Miller, and J.D. Potter Functional analysis of a troponin I (R145G) mutation associated with familial hypertrophic cardiomyopathy J. Biol. Chem. 277 2002 11670 11678
20. J. Marian Modifier genes for hypertrophic cardiomyopathy Curr. Opin. Cardiol. 17 2002 242 252
21. G. Doolan, L. Nguyen, J. Chung, J. Ingles, and C. Semsarian Progression of left ventricular hypertrophy and the angiotensin-converting enzyme (ACE) gene polymorphism in hypertrophic cardiomyopathy Int. J. Cardiol. 96 2004 157 163
22. C. Semsarian, D. Fatkin, M.J. Healey, M. Giewat, C. Duffy, and C.E. Seidman A polymorphic modifier gene alters the hypertrophic response in a murine model of familial hypertrophic cardiomyopathy J. Mol. Cell. Cardiol. 33 2001 2055 2060
23. B.J. Maron, W.K. Shen, M.S. Link, A.E. Epstein, A.K. Almquist, and J.P. Daubert Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy N. Engl. J. Med. 342 2000 365 373
24. G. Boriani, B.J. Maron, W.K. Shen, and P. Spirito Prevention of sudden death in hypertrophic cardiomyopathy. But which defibrillator for which patient? Circulation 110 2004 438 442